my account  log out
 

Mifepristone

Create: 09/28/2016
Expired Date:09/30/2019
Category: Estrone [Health&Medical&Pharmaceutical]
Message: Mifepristone Molecular Formula:C29H35NO2 CAS Registry Number:84371-65-3 Synonyms:Estra-4,9-dien-3-one,11-[4-(dimethylamino)- phenyl]-17-hydroxy-17-(1-propynyl)-,(11a,- 17a)-; Mifepristone [USAN:BAN:INN]; 17-beta-Hydroxy-11-beta-(4-dimethylaminophenyl-1)-17-alpha-(prop-1-ynyl)oestra-4,9-dien-3-one; Mifeprex; Mifepristonum [Latin]; R 38486; RU 38486; 11beta-(4-(Dimethylamino)phenyl)-17beta-hydroxy-17-(1-propynyl)estra-4,9-dien-3-on; Estra-4,9-dien-3-one, 11-[4-(dimethylamino)phenyl]-17-hydroxy-17-(1-propynyl)-, (11b,17b)-; Prestwick_570; Mifegyne; (11beta,17beta)-11-(4-(Dimethylamino)-phenyl)-17-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one; RU-486; RU486; 11beta-(4-(Dimethylamino)phenyl)-17-hydroxy-21-methyl-19-nor-17alpha-pregna-4,9-dien-20-m-3-on; RU 486-6; 17-(1-propynyl)estra-4,9-dien-3-one; Chemical Properties Appearance:Pale Yellow Solid Molecular Weight:429.5937 Density:1.18 g/cm3 Boiling Point:628.6 °C at 760 mmHg Melting Point:195-198°C Flash Point:334 °C Storage Temperature:2-8°C Refractive index:1.623 Solubility:Soluble to 100 mM in DMSO and to 50 mM in Ethanol Biological Activity:Selective antagonist at progesterone (PR) and glucocorticoid (GR) receptors in vitro and in vivo . Is a silent antagonist at PR and has a higher affinity than progesterone. Has higher affinity for GR than dexamethasone. Stability:Stable at normal temperatures and pressures. Usage:A progesterone receptor antagonist with partial agonist activity. Abortifacient. For more details, please contact cindy1114@yccreate.com
City:Wuhan Hubei[CN] 
Location:
 
Sep 29 20163,6-Dichloropyridazine393
Sep 29 2016Cephalomannine398
Sep 29 2016 Notoginseng Triterpenes404
Sep 29 2016 Xanthophyll from alfalfa438
Sep 29 2016 Escin430
Sep 29 2016Eugenol405
Sep 29 2016Scopolamine Butylbromide410
Sep 29 2016 Caryophyllene402
Sep 29 2016 L(-)-Menthol399
Sep 29 2016DHA Powder Schizochytrium389

return back

Copyright © toextrade Inc. All rights reserved. Contact us